Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920148082> ?p ?o ?g. }
- W2920148082 endingPage "659" @default.
- W2920148082 startingPage "652" @default.
- W2920148082 abstract "At a recent consensus conference, the Malignant Hyperthermia Association of the United States addressed 6 important and unresolved clinical questions concerning the optimal management of patients with malignant hyperthermia (MH) susceptibility or acute MH. They include: (1) How much dantrolene should be available in facilities where volatile agents are not available or administered, and succinylcholine is only stocked on site for emergency purposes? (2) What defines masseter muscle rigidity? What is its relationship to MH, and how should it be managed when it occurs? (3) What is the relationship between MH susceptibility and heat- or exercise-related rhabdomyolysis? (4) What evidence-based interventions should be recommended to alleviate hyperthermia associated with MH? (5) After treatment of acute MH, how much dantrolene should be administered and for how long? What criteria should be used to determine stopping treatment with dantrolene? (6) Can patients with a suspected personal or family history of MH be safely anesthetized before diagnostic testing? This report describes the consensus process and the outcomes for each of the foregoing unanswered clinical questions." @default.
- W2920148082 created "2019-03-11" @default.
- W2920148082 creator A5005522839 @default.
- W2920148082 creator A5026229888 @default.
- W2920148082 creator A5046695124 @default.
- W2920148082 creator A5050881160 @default.
- W2920148082 creator A5054162643 @default.
- W2920148082 creator A5057615450 @default.
- W2920148082 creator A5059683724 @default.
- W2920148082 creator A5072111858 @default.
- W2920148082 date "2019-04-01" @default.
- W2920148082 modified "2023-10-01" @default.
- W2920148082 title "Consensus Statement of the Malignant Hyperthermia Association of the United States on Unresolved Clinical Questions Concerning the Management of Patients With Malignant Hyperthermia" @default.
- W2920148082 cites W134113535 @default.
- W2920148082 cites W1815293472 @default.
- W2920148082 cites W1923309553 @default.
- W2920148082 cites W1926732314 @default.
- W2920148082 cites W1963988316 @default.
- W2920148082 cites W1968559564 @default.
- W2920148082 cites W1976783362 @default.
- W2920148082 cites W1977565611 @default.
- W2920148082 cites W1982339015 @default.
- W2920148082 cites W1985025225 @default.
- W2920148082 cites W2001304908 @default.
- W2920148082 cites W2005435382 @default.
- W2920148082 cites W2011297686 @default.
- W2920148082 cites W2015763565 @default.
- W2920148082 cites W2017415739 @default.
- W2920148082 cites W2017506715 @default.
- W2920148082 cites W2025989906 @default.
- W2920148082 cites W2027924830 @default.
- W2920148082 cites W2028938299 @default.
- W2920148082 cites W2031469931 @default.
- W2920148082 cites W2045954062 @default.
- W2920148082 cites W2050557256 @default.
- W2920148082 cites W2058464297 @default.
- W2920148082 cites W2059088010 @default.
- W2920148082 cites W2070293821 @default.
- W2920148082 cites W2074907052 @default.
- W2920148082 cites W2075091214 @default.
- W2920148082 cites W2078093155 @default.
- W2920148082 cites W2080273051 @default.
- W2920148082 cites W2101758219 @default.
- W2920148082 cites W2103939014 @default.
- W2920148082 cites W2105468959 @default.
- W2920148082 cites W2112302963 @default.
- W2920148082 cites W2112906555 @default.
- W2920148082 cites W2114078253 @default.
- W2920148082 cites W2116679600 @default.
- W2920148082 cites W2135137851 @default.
- W2920148082 cites W2137990134 @default.
- W2920148082 cites W2138251630 @default.
- W2920148082 cites W2139746402 @default.
- W2920148082 cites W2141621528 @default.
- W2920148082 cites W2161515375 @default.
- W2920148082 cites W2161753553 @default.
- W2920148082 cites W2163354078 @default.
- W2920148082 cites W2172062766 @default.
- W2920148082 cites W2307347081 @default.
- W2920148082 cites W2325072458 @default.
- W2920148082 cites W2325241185 @default.
- W2920148082 cites W2334524426 @default.
- W2920148082 cites W2411424863 @default.
- W2920148082 cites W2417746216 @default.
- W2920148082 cites W2754781165 @default.
- W2920148082 cites W2778221885 @default.
- W2920148082 cites W4211223349 @default.
- W2920148082 doi "https://doi.org/10.1213/ane.0000000000004039" @default.
- W2920148082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30768455" @default.
- W2920148082 hasPublicationYear "2019" @default.
- W2920148082 type Work @default.
- W2920148082 sameAs 2920148082 @default.
- W2920148082 citedByCount "21" @default.
- W2920148082 countsByYear W29201480822019 @default.
- W2920148082 countsByYear W29201480822020 @default.
- W2920148082 countsByYear W29201480822021 @default.
- W2920148082 countsByYear W29201480822022 @default.
- W2920148082 countsByYear W29201480822023 @default.
- W2920148082 crossrefType "journal-article" @default.
- W2920148082 hasAuthorship W2920148082A5005522839 @default.
- W2920148082 hasAuthorship W2920148082A5026229888 @default.
- W2920148082 hasAuthorship W2920148082A5046695124 @default.
- W2920148082 hasAuthorship W2920148082A5050881160 @default.
- W2920148082 hasAuthorship W2920148082A5054162643 @default.
- W2920148082 hasAuthorship W2920148082A5057615450 @default.
- W2920148082 hasAuthorship W2920148082A5059683724 @default.
- W2920148082 hasAuthorship W2920148082A5072111858 @default.
- W2920148082 hasConcept C118552586 @default.
- W2920148082 hasConcept C126322002 @default.
- W2920148082 hasConcept C177713679 @default.
- W2920148082 hasConcept C27415008 @default.
- W2920148082 hasConcept C2778575482 @default.
- W2920148082 hasConcept C2779379848 @default.
- W2920148082 hasConcept C2779949491 @default.
- W2920148082 hasConcept C2781460320 @default.
- W2920148082 hasConcept C2910132651 @default.
- W2920148082 hasConcept C42219234 @default.
- W2920148082 hasConcept C519063684 @default.